Marielle Fournier and Anne Dupraz-Poiseau describe US and EU rules governing prefilled syringes, pen injectors and innovative drug-delivery systems for biologics and consider the safety, quality and efficacy development challenges for manufacturers.
Anne Dupraz-Poiseau, Marielle Fournier
Marielle Fournier, Senior Director Drugs Devices & Combination Products
Marielle Fournier, Senior Director Drugs, Devices & Combination Products, has a dual expertise within VCLS. The first is the management of projects involving the design and implementation of global regulatory strategies for the development, evaluation and marketing of medical devices & medicinal products, as well as combination products and borderline products. The second is Quality regulations, where she assists in the identification, development and implementation of Quality Systems appropriate to the need, complexity and size of an organization.
Anne Dupraz Poiseau, Executive Vice President
Responsible for the definition of the Corporate Strategy and Business Development implementation plan. Participation in the structuration of the Company to allow future growth (internal and through acquisition). Managerial and expertise responsibilities and acts as senior Advisor on Advanced Therapies Medicinal Products (ATMPs, in particular on cell and tissue based therapies), combination products (drug/device combinations) and medical devices related projects (incl. e- and m-health).